AI News NQ Analysis

Notice of Execution of Letter of Intent for Exclusive Distribution Rights of Korean-made Carbomer for the Chinese Pharmaceutical Excipients Market

NQ Score 72/100
N1 Content Completeness 8

AI Summary (NQ-processed)

Shoko Co., Ltd. has signed an LOI with Hannong Chemicals Inc. (Korea) to secure exclusive distribution rights for Carbomer in China's pharmaceutical excipients market, targeting DMF registration by summer 2026.

AI Analysis

Frequently Asked Questions

Q: What is the carbomer that Showa Tsusho has contracted?
A: It is a water-soluble thickening and gelling agent manufactured by Korean Hannong Chemicals, currently mainly used as a cosmetic ingredient.
Q: What is the purpose of this contract?
A: To expand the sales of carbomer in China's pharmaceutical excipient market (for drug additive compliance purposes).
Q: When is the planned sales start date?
A: The DMF (Drug Master File) registration in China is expected to be completed by summer 2026, with sales to begin promptly thereafter.